GlassScriptPhysician profile
Andrew Schwemmer
NPI 1790179604
$30,111.78
in general payments reported to CMS, 2019-2025
17 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $124 · 2021: $10K · 2022: $18K · 2023: $1,226 · 2024: $148 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $540.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $28,680.35 | 2021-2023 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $355.00 | 2022-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| Integra Lifesciences Corporation | $134.78 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Cook Medical LLC | $118.21 | 2021-2023 | Advance |
| Kci USA, INC. | $97.97 | 2020 | |
| Conmed Corporation | $83.33 | 2021 | |
| C2dx, INC | $63.83 | 2023 | |
| Aroa Biosurgery Incorporated | $50.75 | 2022-2023 | |
| Acera Surgical, INC. | $44.35 | 2024 | Restrata Wound Matrix |
| Medtronic, INC. | $44.32 | 2025 | Pteye Parathyroid Detection System |
| Davol INC. | $42.22 | 2022 | |
| Medline Industries LP | $25.86 | 2025 | |
| Novo Nordisk INC | $22.32 | 2021 | |
| Tela Bio, INC. | $17.76 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $13.13 | 2020 | |
| Redhill Biopharma INC. | $12.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Schwemmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.